Advanced Melanoma

MILLBRAE, Calif., August 11, 2026 Eikon Therapeutics announced the selection of a 0.60 mg/m² dose of EIK1001 for patients...

Burlington, North Carolina, USA, August 10, 2026 Labcorp has announced that the U.S. Food and Drug Administration (FDA) has...

Menlo Park, California, USA, August 8, 2026 GRAIL, Inc. has announced a major regulatory milestone as the U.S. Food...

Woburn, Massachusetts, USA, August 8, 2026 Replimune Group, Inc. has achieved a significant regulatory milestone with the U.S. Food...

Silver Spring, Maryland, USA, August 8, 2026 The U.S. Food and Drug Administration (FDA) has granted accelerated approval to...

SAN CARLOS, Calif., June 3, 2026 Iovance Biotherapeutics has announced that Australia’s Therapeutic Goods Administration (TGA) has granted approval...